Health tech could see more acquisitions after Teladoc-Livongo deal

Jason Gorevic, CEO, Teladoc
Scott Mlyn | CNBC

(This story is for CNBC Pro subscribers only). 

The health technology sector had a big shock on Wednesday as Teladoc and Livongo Health announced a merger worth about $18.5 billion, creating a major player in an industry whose growth has been accelerated by the coronavirus pandemic. 

The deal, negotiated in part while wearing Livongo-branded facemasks in a Detroit hotel, is one of the more high-profile deals in the space, as startups and more established players jockey for position in an expanding market. Shares of both companies fell sharply after the announcement, but both have made significant gains in the past year.

Health tech companies tend to be wary of deals because of previous struggles for large deals, but the industry could be ripe for further consolidation, said Stephanie Davis, a research analyst at SVB Leerink.

More In Pro Insight

CNBC ProThe most widely followed Wall Street investor survey shows big leap in economic fears
watch now
CNBC ProEquities still have further upside despite cost pressures, strategist says
watch now
CNBC ProP&G's Jon Moeller reacts to Q3 earnings, supply chain issues, inflation and more